152 related articles for article (PubMed ID: 23524125)
1. Methylated N-(4-N,N-dimethylaminocinnamyl) chitosan-coated electrospray OVA-loaded microparticles for oral vaccination.
Suksamran T; Ngawhirunpat T; Rojanarata T; Sajomsang W; Pitaksuteepong T; Opanasopit P
Int J Pharm; 2013 May; 448(1):19-27. PubMed ID: 23524125
[TBL] [Abstract][Full Text] [Related]
2. Preparation and in vitro evaluation of mucoadhesive properties of alginate/chitosan microparticles containing prednisolone.
Wittaya-areekul S; Kruenate J; Prahsarn C
Int J Pharm; 2006 Apr; 312(1-2):113-8. PubMed ID: 16490331
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Eudragit-coated chitosan microparticles as an oral immune delivery system.
Hori M; Onishi H; Machida Y
Int J Pharm; 2005 Jun; 297(1-2):223-34. PubMed ID: 15885938
[TBL] [Abstract][Full Text] [Related]
4. Fabrication of microparticle protein delivery systems based on calcium alginate.
Yu CY; Jia LH; Cheng SX; Zhang XZ; Zhuo RX
J Microencapsul; 2010; 27(2):171-7. PubMed ID: 19538029
[TBL] [Abstract][Full Text] [Related]
5. Preparation of coated nanoparticles for a new mucosal vaccine delivery system.
Borges O; Borchard G; Verhoef JC; de Sousa A; Junginger HE
Int J Pharm; 2005 Aug; 299(1-2):155-66. PubMed ID: 15998569
[TBL] [Abstract][Full Text] [Related]
6. Enhancing Stability and Mucoadhesive Properties of Chitosan Nanoparticles by Surface Modification with Sodium Alginate and Polyethylene Glycol for Potential Oral Mucosa Vaccine Delivery.
Amin MK; Boateng JS
Mar Drugs; 2022 Feb; 20(3):. PubMed ID: 35323455
[No Abstract] [Full Text] [Related]
7. Antigen-adjuvant nanoconjugates for nasal vaccination: an improvement over the use of nanoparticles?
Slütter B; Bal SM; Que I; Kaijzel E; Löwik C; Bouwstra J; Jiskoot W
Mol Pharm; 2010 Dec; 7(6):2207-15. PubMed ID: 21043518
[TBL] [Abstract][Full Text] [Related]
8. Alginate coated chitosan microparticles mediated oral delivery of diphtheria toxoid. Part A. Systematic optimization, development and characterization.
Shukla A; Mishra V; Bhoop BS; Katare OP
Int J Pharm; 2015 Nov; 495(1):220-233. PubMed ID: 26319633
[TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of chitosan-treated alginate microparticles incorporating all-trans retinoic acid.
Lira AA; Rossetti FC; Nanclares DM; Neto AF; Bentley MV; Marchetti JM
J Microencapsul; 2009 May; 26(3):243-50. PubMed ID: 18923964
[TBL] [Abstract][Full Text] [Related]
10. Preparation of alginate coated chitosan microparticles for vaccine delivery.
Li X; Kong X; Shi S; Zheng X; Guo G; Wei Y; Qian Z
BMC Biotechnol; 2008 Nov; 8():89. PubMed ID: 19019229
[TBL] [Abstract][Full Text] [Related]
11. β-Glucan microparticles are good candidates for mucosal antigen delivery in oral vaccination.
De Smet R; Demoor T; Verschuere S; Dullaers M; Ostroff GR; Leclercq G; Allais L; Pilette C; Dierendonck M; De Geest BG; Cuvelier CA
J Control Release; 2013 Dec; 172(3):671-8. PubMed ID: 24041710
[TBL] [Abstract][Full Text] [Related]
12. Mucoadhesive microspheres for nasal administration of an antiemetic drug, metoclopramide: in-vitro/ex-vivo studies.
Gavini E; Rassu G; Sanna V; Cossu M; Giunchedi P
J Pharm Pharmacol; 2005 Mar; 57(3):287-94. PubMed ID: 15807983
[TBL] [Abstract][Full Text] [Related]
13. Chitosan oligosaccharide as prospective cross-linking agent for naproxen-loaded Ca-alginate microparticles with improved pH sensitivity.
Čalija B; Milić J; Cekić N; Krajišnik D; Daniels R; Savić S
Drug Dev Ind Pharm; 2013 Jan; 39(1):77-88. PubMed ID: 22339172
[TBL] [Abstract][Full Text] [Related]
14. Preparation of N,O-carboxymethyl chitosan coated alginate microcapsules and their application to Bifidobacterium longum BIOMA 5920.
Mi Y; Su R; Fan DD; Zhu XL; Zhang WN
Mater Sci Eng C Mater Biol Appl; 2013 Jul; 33(5):3047-53. PubMed ID: 23623131
[TBL] [Abstract][Full Text] [Related]
15. Adjuvanted, antigen loaded N-trimethyl chitosan nanoparticles for nasal and intradermal vaccination: adjuvant- and site-dependent immunogenicity in mice.
Bal SM; Slütter B; Verheul R; Bouwstra JA; Jiskoot W
Eur J Pharm Sci; 2012 Mar; 45(4):475-81. PubMed ID: 22009113
[TBL] [Abstract][Full Text] [Related]
16. Uptake studies in rat Peyer's patches, cytotoxicity and release studies of alginate coated chitosan nanoparticles for mucosal vaccination.
Borges O; Cordeiro-da-Silva A; Romeijn SG; Amidi M; de Sousa A; Borchard G; Junginger HE
J Control Release; 2006 Sep; 114(3):348-58. PubMed ID: 16905219
[TBL] [Abstract][Full Text] [Related]
17. Preparation of chitosan/alginate/calcium complex microparticles loaded with lactoferrin and their efficacy on carrageenan-induced edema in rats.
Onishi H; Koyama K; Sakata O; Machida Y
Drug Dev Ind Pharm; 2010 Aug; 36(8):879-84. PubMed ID: 20345284
[TBL] [Abstract][Full Text] [Related]
18. Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: nanoparticle characteristics determine quality and strength of the antibody response in mice against the encapsulated antigen.
Slütter B; Bal S; Keijzer C; Mallants R; Hagenaars N; Que I; Kaijzel E; van Eden W; Augustijns P; Löwik C; Bouwstra J; Broere F; Jiskoot W
Vaccine; 2010 Aug; 28(38):6282-91. PubMed ID: 20638455
[TBL] [Abstract][Full Text] [Related]
19. Co-encapsulation of an antigen and CpG oligonucleotides into PLGA microparticles by TROMS technology.
San Román B; Irache JM; Gómez S; Tsapis N; Gamazo C; Espuelas MS
Eur J Pharm Biopharm; 2008 Sep; 70(1):98-108. PubMed ID: 18501572
[TBL] [Abstract][Full Text] [Related]
20. Conjugation of ovalbumin to trimethyl chitosan improves immunogenicity of the antigen.
Slütter B; Soema PC; Ding Z; Verheul R; Hennink W; Jiskoot W
J Control Release; 2010 Apr; 143(2):207-14. PubMed ID: 20074597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
